Feedback / Questions
Piqray (alpelisib) - Novartis
Piqray: Regulatory approval in EU for HR+/HER2- advanced breast cancer in 2020
(Novartis)
-
Oct 14, 2019 -
Kisqali MONALEESA-3 ESMO Data Investor Call
European regulatory
https://www.novartis.com/sites/www.novartis.com/files/2019-10-novartis-esmo-investor-call-presentation.pdf
Oct 14, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious